Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 14
2003 14
2004 22
2005 20
2006 20
2007 21
2008 30
2009 25
2010 26
2011 40
2012 28
2013 30
2014 46
2015 31
2016 32
2017 33
2018 34
2019 39
2020 38
2021 45
2022 22
Text availability
Article attribute
Article type
Publication date

Search Results

547 results
Results by year
Filters applied: . Clear all
Page 1
Periodontal Disease in Patients Receiving Dialysis.
Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H, Nishino T, Yoshimura A, Sakai H. Miyata Y, et al. Among authors: sakai h. Int J Mol Sci. 2019 Aug 3;20(15):3805. doi: 10.3390/ijms20153805. Int J Mol Sci. 2019. PMID: 31382656 Free PMC article. Review.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators. Diener HC, et al. N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959. N Engl J Med. 2019. PMID: 31091372 Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
Met in urological cancers.
Miyata Y, Asai A, Mitsunari K, Matsuo T, Ohba K, Mochizuki Y, Sakai H. Miyata Y, et al. Among authors: sakai h. Cancers (Basel). 2014 Dec 16;6(4):2387-403. doi: 10.3390/cancers6042387. Cancers (Basel). 2014. PMID: 25521854 Free PMC article. Review.
Total Synthesis of Decahydroquinoline Poison Frog Alkaloids ent-cis-195A and cis-211A.
Okada T, Wu N, Takashima K, Ishimura J, Morita H, Ito T, Kodama T, Yamasaki Y, Akanuma SI, Kubo Y, Hosoya KI, Tsuneki H, Wada T, Sasaoka T, Shimizu T, Sakai H, Dwoskin LP, Hussaini SR, Saporito RA, Toyooka N. Okada T, et al. Among authors: sakai h. Molecules. 2021 Dec 12;26(24):7529. doi: 10.3390/molecules26247529. Molecules. 2021. PMID: 34946611 Free PMC article.
Pathological significance and prognostic role of LATS2 in prostate cancer.
Matsuda T, Miyata Y, Nakamura Y, Otsubo A, Mukae Y, Harada J, Mitsunari K, Matsuo T, Ohba K, Furusato B, Sakai H. Matsuda T, et al. Among authors: sakai h. Prostate. 2021 Nov;81(15):1252-1260. doi: 10.1002/pros.24226. Epub 2021 Sep 7. Prostate. 2021. PMID: 34492128
547 results